| Literature DB >> 19029012 |
Caroline Engeloch1, Ulrich Schopfer, Ingo Muckenschnabel, Francois Le Goff, Hervé Mees, Karoline Boesch, Maxim Popov.
Abstract
The impact of storage conditions on compound stability and compound solubility has been debated intensely over the past 5 years. At Novartis, the authors decided to opt for a storage concept that can be considered controversial because they are using a DMSO/water (90/10) mixture as standard solvent. To assess the effect of water in DMSO stocks on compound stability, the authors monitored the purity of a subset of 1404 compounds from ongoing medicinal chemistry projects over several months. The study demonstrated that 85% of the compounds were stable in wet DMSO over a 2-year period at 4 degrees C. This result validates the storage concept developed at Novartis as a pragmatic approach that takes advantage of the benefits of DMSO/water mixtures while mediating the disadvantages. In addition, the authors describe how purity data collected over the course of the chemical validation of high-throughput screening actives are used to improve the analytical quality of the Novartis screening deck.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19029012 DOI: 10.1177/1087057108326536
Source DB: PubMed Journal: J Biomol Screen ISSN: 1087-0571